Unravelling subclonal heterogeneity and aggressive disease states in TNBC through single-cell RNA-seq
Triple-negative breast cancer is highly heterogeneous and aggressive. Here, the authors utilise single-cell RNA sequencing to investigate this heterogeneity, and discover a subpopulation of cells associated with metastasis and treatment resistance signatures, and linked to long term survival outcome...
Guardado en:
Autores principales: | Mihriban Karaayvaz, Simona Cristea, Shawn M. Gillespie, Anoop P. Patel, Ravindra Mylvaganam, Christina C. Luo, Michelle C. Specht, Bradley E. Bernstein, Franziska Michor, Leif W. Ellisen |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2018
|
Materias: | |
Acceso en línea: | https://doaj.org/article/afc5c409cf52474faf19d8ea9034f824 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Role of PARP in TNBC: Mechanism of Inhibition, Clinical Applications, and Resistance
por: Desh Deepak Singh, et al.
Publicado: (2021) -
Post-Hypoxic Cells Promote Metastatic Recurrence after Chemotherapy Treatment in TNBC
por: Inês Godet, et al.
Publicado: (2021) -
Epigenetic regulation of triple negative breast cancer (TNBC) by TGF-β signaling
por: Radhakrishnan Vishnubalaji, et al.
Publicado: (2021) -
Combating subclonal evolution of resistant cancer phenotypes
por: Samuel W. Brady, et al.
Publicado: (2017) -
Nanosized functional miRNA liposomes and application in the treatment of TNBC by silencing Slug gene
por: Yan Y, et al.
Publicado: (2019)